Eagle Pharmaceuticals, Inc. (EGRX)
OTCMKTS · Delayed Price · Currency is USD
0.7000
+0.3600 (105.88%)
Dec 31, 2025, 4:00 PM EST
Eagle Pharmaceuticals Market Cap
Eagle Pharmaceuticals has a market cap or net worth of $9.12 million as of January 2, 2026. Its market cap has decreased by -86.60% in one year.
Market Cap
9.12M
Enterprise Value
n/a
Revenue
257.55M
Ranking
n/a
PE Ratio
0.77
Stock Price
$0.70
Market Cap Chart
Since February 12, 2014, Eagle Pharmaceuticals's market cap has decreased from 39.11M to 9.12M, a decrease of -76.69%. That is a compound annual growth rate of -11.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 9.12M | 40.00% |
| Dec 31, 2024 | 6.51M | -90.41% |
| Dec 29, 2023 | 67.92M | -82.15% |
| Dec 30, 2022 | 380.45M | -42.14% |
| Dec 31, 2021 | 657.57M | 8.37% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Glass House Brands | 710.35M |
| Elite Pharmaceuticals | 526.71M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 356.97M |
| CytoDyn | 355.55M |
| Silence Therapeutics | 287.18M |